Last year, the EMCDDA celebrated 25 years of monitoring the drug situation in Europe. In the quarter of a century since the a ... gency embarked on its first work programme in 1995, we have seen revolutionary changes, both in the extent and nature of the drugs problem, and in the world in which we live. Keeping pace with an increasingly dynamic drug phenomenon, while remaining relevant to policy and practice, requires constant reflection, innovation and agility. This is why we will be developing a new business model as we pursue our vision to contribute to a healthier and more secure Europe. read more
Competitor | Description | Similarity |
---|
Loading..